# CoreRX Inc. – FDA Inspection, Nov 10, 2016

Source: https://www.keypedia.com/records/fda_inspections/corerx-inc/100fb894-1bd2-44db-9908-377def8e5acc
Source feed: FDA_Inspections

> FDA inspection 992071 of CoreRX Inc., November 10, 2016. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 992071
- Company Name: CoreRX Inc.
- Inspection Date: 2016-11-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1304588 - 2026-02-26](https://www.keypedia.com/records/fda_inspections/corerx-inc/956f34ef-816f-43f4-bdfd-ba4552b1e37e)
- [FDA Inspection 1264769 - 2025-03-20](https://www.keypedia.com/records/fda_inspections/corerx-inc/2ad11a9c-e4df-4503-8667-a3b01206638f)
- FDA Inspection 1151289 - 2021-08-13
- FDA Inspection 1119912 - 2020-03-06
- [FDA Inspection 1094038 - 2019-06-21](https://www.keypedia.com/records/fda_inspections/corerx-inc/b803f376-82ec-4a52-865c-0160cdf3770b)

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)

Company: https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9